NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









On Target Laboratories

On Target Laboratories

Private
West Lafayette, IndianaHealthcare & Life Scienceshttps://ontargetlabs.com/

Last Round

Series C

Nov 16, 2023

Total Funding Raised

$162.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

On Target Laboratories is a biotechnology company that develops targeted intraoperative molecular imaging agents to illuminate cancer during surgical procedures.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

fluorescent imaging agentsurgical oncologycancer resectionintraoperative imagingtumor visualizationnear-infrared imagingpafolacianinecancer surgeryimage-guided surgeryfluorescence-guided surgerybiotechnologysurgical navigationmolecular imagingsurgical oncology toolscancer detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

On Target Laboratories Comparables

Compare On Target Laboratories with similar companies based on industry and business-model similarity.

On Target Laboratories comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

On Target Laboratories Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 16, 2023
Series B ExtensionMar 24, 2021
Series B ExtensionMar 14, 2018
Series BNov 2, 2017
Series BSep 1, 2017
Follow-on Offering
May 1, 2015

Key People

Founding team and executive leadership

Philip Low

Co-Founder And Chief Science Officer

Founding Team

Bill Peters

Chief Executive Officer

Executive Team

On Target Laboratories Investors

Notable investors and investment history

On Target Laboratories investors
InvestorRounds
Olympus Innovation VenturesSeries C
Orion Capital AsiaSeries C
Elevate VenturesSeries B, Series C, Series B Extension
3B FUTURE Health FundSeries C, Series B Extension
HIG BioHealth PartnersSeries B, Series B Extension
Pension Fund of the Christian ChurchFollow-on Offering, Early Funding, Series C
Johnson & Johnson Innovation – JJDCSeries B Extension, Series C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 24, 2026

    Named to Fast Company's Most Innovative Companies list.

  • Feb 11, 2026

    Product used in approximately 1,500 commercial procedures to date.

On Target Laboratories Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

On Target Laboratories Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about On Target Laboratories's valuation, stock price, and market status.

Firmographic Details

HeadquartersWest Lafayette, Indiana
Employee Range80
Year Founded2010
Last FundingNov 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.